- Home
- GANX vs MDIA Comparison
GANX vs MDIA Comparison
Compare GANX & MDIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GANX
- MDIA
- Stock Information
- Founded
- GANX 2017
- MDIA 2019
- Country
- GANX United States
- MDIA United States
- Employees
- GANX N/A
- MDIA N/A
- Industry
- GANX Biotechnology: Pharmaceutical Preparations
- MDIA Broadcasting
- Sector
- GANX Health Care
- MDIA Consumer Discretionary
- Exchange
- GANX Nasdaq
- MDIA Nasdaq
- Market Cap
- GANX 57.9M
- MDIA 51.8M
- IPO Year
- GANX 2021
- MDIA N/A
- Fundamental
- Price
- GANX $1.93
- MDIA $1.10
- Analyst Decision
- GANX Strong Buy
- MDIA
- Analyst Count
- GANX 5
- MDIA 0
- Target Price
- GANX $8.20
- MDIA N/A
- AVG Volume (30 Days)
- GANX 226.2K
- MDIA 41.3K
- Earning Date
- GANX 05-14-2025
- MDIA 05-20-2025
- Dividend Yield
- GANX N/A
- MDIA N/A
- EPS Growth
- GANX N/A
- MDIA N/A
- EPS
- GANX N/A
- MDIA N/A
- Revenue
- GANX N/A
- MDIA $116,895,000.00
- Revenue This Year
- GANX N/A
- MDIA N/A
- Revenue Next Year
- GANX N/A
- MDIA N/A
- P/E Ratio
- GANX N/A
- MDIA N/A
- Revenue Growth
- GANX N/A
- MDIA 268.03
- 52 Week Low
- GANX $0.89
- MDIA $0.79
- 52 Week High
- GANX $3.19
- MDIA $5.73
- Technical
- Relative Strength Index (RSI)
- GANX 53.25
- MDIA 54.27
- Support Level
- GANX $1.80
- MDIA $0.95
- Resistance Level
- GANX $1.85
- MDIA $1.30
- Average True Range (ATR)
- GANX 0.13
- MDIA 0.09
- MACD
- GANX -0.00
- MDIA 0.03
- Stochastic Oscillator
- GANX 60.00
- MDIA 55.78
About GANX Gain Therapeutics Inc.
Gain Therapeutics Inc is a biotechnology company developing novel small molecule therapeutics to treat diseases across several therapeutic areas, including, lysosomal storage disorders, central nervous system disorders, metabolic disorders, and oncology. The company's clinical-stage product candidate, GT-02287, is being developed for the treatment of GBA1 Parkinson's disease. The company uses its computational target and drug discovery platform, Magellan, to discover novel allosteric binding sites on proteins implicated in disease and to identify proprietary small molecules that bind these sites to modulate protein function and treat the underlying cause of the disease. Geographically, the company operates in Switzerland, Spain, the United States, and Australia.
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.